KR20100093223A - Cosmetic composition containing an extract of ophiopogon japonicus for skin miosture - Google Patents
Cosmetic composition containing an extract of ophiopogon japonicus for skin miostureInfo
- Publication number
- KR20100093223A KR20100093223A KR1020090012314A KR20090012314A KR20100093223A KR 20100093223 A KR20100093223 A KR 20100093223A KR 1020090012314 A KR1020090012314 A KR 1020090012314A KR 20090012314 A KR20090012314 A KR 20090012314A KR 20100093223 A KR20100093223 A KR 20100093223A
- Authority
- KR
- South Korea
- Prior art keywords
- skin
- extract
- cosmetic composition
- moisturizing
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000284 extract Substances 0.000 title claims abstract description 55
- 239000000203 mixture Substances 0.000 title claims abstract description 49
- 239000002537 cosmetic Substances 0.000 title claims abstract description 43
- 244000248557 Ophiopogon japonicus Species 0.000 title description 2
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 44
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 12
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 10
- 230000001965 increasing effect Effects 0.000 claims abstract description 6
- 238000009472 formulation Methods 0.000 claims description 16
- 239000006071 cream Substances 0.000 claims description 12
- 239000006210 lotion Substances 0.000 claims description 10
- -1 pack Substances 0.000 claims description 9
- 102100028314 Filaggrin Human genes 0.000 claims description 6
- 101710088660 Filaggrin Proteins 0.000 claims description 6
- 239000007921 spray Substances 0.000 claims description 6
- 230000001737 promoting effect Effects 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 4
- 239000000686 essence Substances 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 2
- 210000003491 skin Anatomy 0.000 abstract description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 24
- 102000004169 proteins and genes Human genes 0.000 abstract description 10
- 108090000623 proteins and genes Proteins 0.000 abstract description 10
- 210000000434 stratum corneum Anatomy 0.000 abstract description 7
- 210000002615 epidermis Anatomy 0.000 abstract description 6
- 102000000591 Tight Junction Proteins Human genes 0.000 abstract description 3
- 108010002321 Tight Junction Proteins Proteins 0.000 abstract description 3
- 210000001578 tight junction Anatomy 0.000 abstract description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- 230000000052 comparative effect Effects 0.000 description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 16
- 210000002510 keratinocyte Anatomy 0.000 description 14
- 238000000926 separation method Methods 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 238000002845 discoloration Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 238000001704 evaporation Methods 0.000 description 8
- 230000008020 evaporation Effects 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- 241000283690 Bos taurus Species 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 230000002335 preservative effect Effects 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 238000013329 compounding Methods 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- 229920001214 Polysorbate 60 Polymers 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 4
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 4
- 229940113124 polysorbate 60 Drugs 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- 238000001262 western blot Methods 0.000 description 3
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical group C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000263 cytotoxicity test Toxicity 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 238000001378 electrochemiluminescence detection Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000005374 membrane filtration Methods 0.000 description 2
- 230000037311 normal skin Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000000541 pulsatile effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 230000036572 transepidermal water loss Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241000255777 Lepidoptera Species 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 241001532026 Liriope muscari Species 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 208000034874 Product colour issue Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910021502 aluminium hydroxide Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 235000012216 bentonite Nutrition 0.000 description 1
- 229940079894 benzophenone-9 Drugs 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000022534 cell killing Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000007398 colorimetric assay Methods 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 238000002784 cytotoxicity assay Methods 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000010389 delta-tocopherol Nutrition 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 150000001983 dialkylethers Chemical class 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- QDCHWIWENYCPIL-UHFFFAOYSA-L disodium;4-hydroxy-5-(2-hydroxy-4-methoxy-5-sulfonatobenzoyl)-2-methoxybenzenesulfonate Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC(S([O-])(=O)=O)=C(OC)C=C1O QDCHWIWENYCPIL-UHFFFAOYSA-L 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 229910052754 neon Inorganic materials 0.000 description 1
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 235000012736 patent blue V Nutrition 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000007103 stamina Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 239000002446 δ-tocopherol Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 소엽맥문동 추출물을 함유하는 피부 보습용 화장료 조성물에 관한 것으로서, 보다 상세하게는 소엽맥문동 추출물이 표피층의 타이트 정션(Tight junction)을 구성하는 단백질인 클라우딘-1(Claudins-1)과 조눌라 오큘루딘-1(Zonula occuluden-1(ZO-1))의 합성을 촉진시켜 수분 손실을 막고 각질층의 천연보습인자(NMF) 함량을 증가시킴으로써 각질층의 보습력을 향상시킨다.The present invention relates to a cosmetic composition for moisturizing skin containing leaflet vegetation extract, and more specifically, leaflet vegetation extract is a protein that forms a tight junction of the epidermal layer, Claudins-1 and zonula. It promotes the synthesis of zonula occuluden-1 (ZO-1), prevents water loss and increases the moisturizing factor of the stratum corneum by increasing its natural moisturizing factor (NMF) content.
Description
본 발명은 소엽맥문동 추출물을 함유하는 피부 보습용 화장료 조성물에 관한 것으로서, 보다 상세하게는 소엽맥문동 추출물이 표피층의 타이트 정션(Tight junction)을 구성하는 단백질인 클라우딘-1(Claudins-1)과 조눌라 오큘루딘-1(Zonula occuluden-1(ZO-1))의 합성을 촉진시켜 수분 손실을 막고 각질층의 천연보습인자(NMF) 함량을 증가시킴으로써 각질층의 보습력을 향상시킨다.The present invention relates to a cosmetic composition for moisturizing skin containing leaflet vegetation extract, and more specifically, leaflet vegetation extract is a protein that forms a tight junction of the epidermal layer, Claudins-1 and zonula. It promotes the synthesis of zonula occuluden-1 (ZO-1), prevents water loss and increases the moisturizing factor of the stratum corneum by increasing its natural moisturizing factor (NMF) content.
인체에 있어서 피부는 외부환경으로부터 생체를 보호하는 보호막의 기능을 하는 기관으로서, 인체 내의 생체성분 즉, 물이나 전해질 등의 손실을 방지하는 동시에 외부로부터 유해물질이 인체 내로 침입하지 못하도록 하는 역할을 한다. 이러한 피부는 크게 표피층, 진피층 및 피하 지방층으로 구분된다. 표피층은 각질 세포와 멜라닌 세포로 구성되는데, 피부 최 외각에 존재하는 각질 세포층은 외부환경과 직접 접촉하기 때문에 물리적, 화학적 혹은 물질의 투과에 대한 강한 저항성이 요구되며, 인체로부터 외부로 수분이 손실되는 것을 막아줌과 동시에 자체로도 적당한 수분을 보유함으로써 유연성을 유지하여야 한다.In the human body, the skin acts as a protective film to protect the living body from the external environment. It prevents the loss of biological components such as water or electrolytes and prevents harmful substances from entering the body. . Such skin is largely divided into epidermal layer, dermis layer and subcutaneous fat layer. The epidermal layer is composed of keratinocytes and melanocytes. Since the keratinocyte layer on the outermost surface of the skin is in direct contact with the external environment, strong resistance to physical, chemical, or permeation of substances is required, and moisture is lost from the human body to the outside. In addition, it must maintain flexibility by retaining adequate moisture on its own.
일반적으로 피부의 수분량은 진피층에서는 70% 정도이나 표피층으로 갈수록 감소하여 각질 세포층에서는 약 10 내지 30%가 된다. 진피층에서 공급된 물은 주로 수동적 확산에 의해 각질층 상부로 이동하며 최종적으로는 외부로 배출된다. 이를 경피수분 손실(Trans Epidermal Water Loss: TEWL)이라 하는데, 이러한 경피수분 손실은 각질 세포층의 지질막 성분인 피지성분과 표피지질에 의해 적절한 수준으로 유지되는 것으로 알려져 있다. 또한, 각질 세포층에는 천연보습 인자(Natural Moisturizing Factor: NMF)라고 하는 친수성의 수분 보유 능을 가진 물질이 존재하여, 피부의 보습에 중요한 역할을 담당하는 것으로 알려져 있다. 각질 세포층의 수분이 10 내지 30% 정도로 유지되면 피부는 매끄럽고 부드러우며, 신체 보호기능을 정상적으로 발휘하게 된다. 그러나, 각질 세포층의 수분함량이 10% 이하가 되면 피부는 거칠어지고 신체의 보호기능을 잃게 되어 노화현상이 일어난다. 예를 들어, 건성피부의 경우에는 각질 세포의 결집력이 약화되어 피부표면으로부터 비늘조각과 같이 각질 세포가 허옇게 벗겨져 나오는 스케일(Scale) 현상이 나타나는데, 이와 같이 피부가 건성화 되는 것은 각질 세포층의 수분함량이 정상피부에 비해 적기 때문이다. 이 밖에, 건강한 피부라 할지라도 혹독한 외부환경 즉, 바람, 추운 날씨, 햇빛, 세안, 면도 등에 의해 수분 부족현상이 일어나 피부상태가 나빠지기도 한다. 따라서, 피부의 각질 세포층의 수분함량을 적절히 유지하는 것은 매우 중요하다.Generally, the moisture content of the skin is about 70% in the dermal layer, but decreases gradually toward the epidermal layer, which is about 10 to 30% in the keratinocyte layer. The water supplied from the dermal layer is mainly moved up the stratum corneum by passive diffusion and finally discharged to the outside. This is called trans epidermal water loss (TEWL), which is known to be maintained at an appropriate level by the sebaceous component and the epidermal lipid, which are lipid membrane components of the keratinocyte layer. In addition, a substance having a hydrophilic water retention capability called a natural moisturizing factor (NMF) exists in the keratinocyte layer and is known to play an important role in moisturizing the skin. When the moisture of the keratinocyte layer is maintained at about 10 to 30%, the skin is smooth and soft, and the body protects normally. However, when the moisture content of the keratinocyte layer is less than 10%, the skin becomes rough and the body loses its protective function, causing aging. For example, in the case of dry skin, the cohesion of keratinocytes is weakened, and the scale phenomenon in which keratinocytes are peeled off from the surface of the skin like scales appears. This is because it is less than normal skin. In addition, even healthy skin may suffer from a lack of moisture due to harsh external environment, ie, wind, cold weather, sunlight, face wash, shaving, and the like, and thus worsens the skin condition. Therefore, it is very important to properly maintain the water content of the keratinocyte layer of the skin.
이를 위하여 화장품에는 피지와 유사한 성분이나 NMF 성분, 또는 폴리올과 같은 보습제 등이 첨가되어 사용되었다. 예를 들어, 수용성 폴리올로서 수산기(OH 기)가 3개 이상인 글리세린, 솔비톨 등이 첨가되었는데, 이들은 뛰어난 보습력을 나타내나 끈적임이 심하여 사용할 때 불쾌감을 느끼게 하고 상대 습도에 따라 피부 내 수분을 빼앗아 가는 문제점이 있고, 수산기(OH 기)가 2개인 프로필렌글리콜, 1,3-부틸렌글리콜 등은 첨가 시 피부의 부작용이 발생하기도 한다. 또한, 다른 천연보습인자인 피롤리돈 카르복실산 나트륨(PCA-Na), 젖산나트륨(Sodium lactate), 요소 등의 첨가물은 전해성이 강해 화장료의 유화안정성을 해치는 문제점이 있으며, 아미노산, 콜라겐, 엘라스틴 등도 보습능력이 있다고 하나 그 보습능력에는 한계가 있다. To this end, cosmetics such as sebum-like components, NMF components, or moisturizers such as polyols were added and used. For example, glycerin, sorbitol, etc., which have three or more hydroxyl groups (OH groups) as water-soluble polyols, have been added, but they exhibit excellent moisturizing power, but are sticky, causing unpleasant feelings and depriving moisture in the skin according to relative humidity. In addition, propylene glycol, 1,3-butylene glycol, etc. having two hydroxyl groups (OH groups) may cause side effects of the skin upon addition. In addition, additives such as sodium pyrrolidone carboxylate (PCA-Na), sodium lactate, and urea, which are other natural moisturizing factors, are highly electrolytic and have a problem of impairing the emulsion stability of cosmetics.Amino acids, collagen, elastin The back has moisturizing ability, but its moisturizing ability is limited.
한편, 일본특허 제2000-212020호에는 분기형 지방산 콜레스테롤 에스테르와 수첨 레시친, 디알킬에테르를 함유시켜 전술한 문제점을 해결하려는 기술이 개시되어 있다. 그러나, 콜레스테롤 유도체는 용해성에 문제가 있고, 다량 사용할 경우 무거움과 끈적임 등이 나타나므로 사용감이 저하된다On the other hand, Japanese Patent No. 2000-212020 discloses a technique for solving the above problems by containing a branched fatty acid cholesterol ester, hydrogenated lecithin, and dialkyl ether. However, cholesterol derivatives have a problem in solubility, and when used in a large amount, heaviness and stickiness appear, resulting in decreased feeling of use.
따라서, 본 발명이 이루고자 하는 기술적 과제는 상기 문제점을 해결하여 피부 자극이 없고 보습 효과가 우수한 피부 보습용 화장료 조성물을 제공하데 있다.Therefore, the technical problem to be achieved by the present invention is to solve the above problems to provide a skin moisturizing cosmetic composition having no skin irritation and excellent moisturizing effect.
따라서, 본 발명의 목적은 소엽맥문동 추출물을 유효성분으로 포함하는 피부 보습용 화장료 조성물을 제공하는데 있다.Therefore, it is an object of the present invention to provide a cosmetic composition for moisturizing the skin comprising the leaflet vegetation extract as an active ingredient.
상술한 과제를 해결하기 위하여 본 발명에 따른 피부보습용화장료 조성물은 다음과 같은 수단을 포함할 수 있다.In order to solve the above problems, the skin moisturizing cosmetic composition according to the present invention may include the following means.
본 발명의 일 실시예에 따르면, 본 발명에 따른 피부 보습용 화장료 조성물은 소엽맥문동 추출물을 유효성분으로 함유한다.According to one embodiment of the present invention, the skin moisturizing cosmetic composition according to the present invention contains lobular vegetation extract as an active ingredient.
본 발명의 다른 실시예에 따르면, 본 발명에 따른 피부 보습용 화장료 조성물에 있어서, 상기 소엽맥문동 추출물은 화장료 조성물 총 중량에 대해서 0.001~20.0 중량%로 함유되는 것을 특징으로 한다.According to another embodiment of the present invention, in the skin moisturizing cosmetic composition according to the present invention, the leaflet vegetation extract is characterized in that it is contained in 0.001 ~ 20.0% by weight relative to the total weight of the cosmetic composition.
본 발명의 또 다른 실시예에 따르면, 본 발명에 따른 피부 보습용 화장료 조성물에 있어서, 상기 소엽맥문동 추출물은 i) Claudins-1과 Zonula occuluden-1(ZO-1)의 합성 촉진, ii) 필라그린 합성 촉진 또는 iii) NMF 증가 및 이의 조합의 작용을 나타내는 것을 특징으로 한다.According to another embodiment of the present invention, in the skin moisturizing cosmetic composition according to the present invention, the leaflet pulsatile extract is i) promoting the synthesis of Claudins-1 and Zonula occuluden-1 (ZO-1), ii) filaggrin Promoting synthesis or iii) increasing NMF and combinations thereof.
본 발명의 다른 실시예에 따르면, 본 발명에 따른 피부 보습용 화장료 조성물에 있어서, 상기 화장료 조성물은 화장수, 에센스, 로션, 크림, 팩, 젤, 연고, 패취, 또는 분무제의 제형을 갖는 것을 특징으로 한다.According to another embodiment of the present invention, in the skin moisturizing cosmetic composition according to the present invention, the cosmetic composition is characterized in that it has a formulation of a lotion, essence, lotion, cream, pack, gel, ointment, patch, or spray. do.
본 발명은 소엽맥문동 추출물을 함유하여 소엽맥문동 추출물이 표피층의 클라우딘-1(Claudins-1)과 조눌라 오큘루딘-1(Zonula occuluden-1(ZO-1))의 합성을 촉진시켜 타이트 정션(Tight junction)의 형성을 도와 수분 손실을 막고 각질층의 천연보습인자(NMF) 함량을 증가시킴으로써 각질층의 보습력을 향상시키는 피부 보습용 화장료 조성물을 제공한다. In the present invention, the leaflet vegetation extract contains leaflet vegetation extract, and the leaflet vegetation extract promotes the synthesis of claudins-1 and zonula occuluden-1 (ZO-1) in the epidermal layer. It provides a cosmetic composition for moisturizing the skin to improve the moisturizing power of the stratum corneum by helping to form a junction () to prevent moisture loss and increase the natural moisturizing factor (NMF) content of the stratum corneum.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명은 소엽맥문동 추출물을 함유하여 타이트 정션(tight junction)의 형성을 도와 수분 손실을 막고 각질층의 천연보습인자(NMF) 함량을 증가시킴으로써 각질층의 보습력을 향상시키는 화장료 조성물을 제공한다.The present invention provides a cosmetic composition to improve the moisturizing ability of the stratum corneum by containing the leaflet vegetation extract to help the formation of a tight junction to prevent moisture loss and increase the natural moisturizing factor (NMF) content of the stratum corneum.
본 발명자들은 천연에서 자생하는 동식물들을 대상으로 보습 효과가 뛰어난 물질을 탐색하기 위하여 연구를 수행한 결과 소엽맥문동 추출물의 보습 효과가 탁월함을 확인하고 본 발명을 완성하였다.The present inventors conducted a study to search for substances having excellent moisturizing effect on native plants and animals, and confirmed that the moisturizing effect of the lobular vegetation extract was excellent and completed the present invention.
본 발명에서 이용되는 소엽맥문동(Ophiopogon japonicus,小葉麥門冬)은 외떡잎식물 백합목 백합과에 속하는 다년생 초본 식물로서 보통의 맥문동(Liriope platyphylla)에 비해 잎이 특히 작고 가늘게 생겼기 때문에 "소엽"맥문동이라 한다. 주로 산지의 응달에서 자란다. 뿌리줄기가 옆으로 뻗으면서 자라고 뿌리 끝이 땅콩같이 굵어지는 것도 있다. 잎은 밑에서 뭉쳐나고 선형이며 나비 2∼4mm이다. 꽃은 5월에 피고 연한 자주색 또는 백색이며 10개 내외가 총상으로 달린다. 가장자리가 막질(膜質: 얇은 종이처럼 반투명한 것)이고 바소꼴인 포 사이에 1∼2개씩 난다. 꽃줄기는 길이 7∼12cm이고 편평하며 예리한 능선이 있다. 작은 꽃줄기는 중앙 또는 꽃 밑에 마디가 있다. 꽃잎과 수술은 6개씩이고 꽃밥은 바소꼴이나 열매는 둥글며 짙은 하늘색이다. 덩이뿌리를 맥문동(麥門冬)과 같이 약용으로 한다. 한국, 일본, 중국, 타이완 등지에 분포한다. 신농본초경에서는 심장의 열을 내려주고, 음을 증강시키는 효능이 있다고 알려져 있고, 폐를 튼튼하게 하고 원기를 돋우며 겨울철 체력을 증진시켜 주고 기침과 천식을 예방하는데 뛰어난 효과가 있다. 해수 천식이 있는 노인이나 폐 수술을 받은 사람이 겨울을 이기기 위한 처방, 또한 열을 내려주는 작용이 있어서 신경 신경통, 류머티즘에도 효과가 있을 뿐 아니라 산모가 아이를 낳고 젖이 잘 안 나올 때 차로 다려 마시면 탁월한 효과를 볼 수 있다. 갈증해소, 피부건조, 겨울철 감기, 피로를 회복시켜 주는 것으로 보고된 바 있으며, 스테로이드계 사포닌 성분과 오피오포고닌(ophiopogonin)등이 주요 성분으로 알려져 있다. 본 발명에서 이용되는 소엽맥문동은 꽃잎, 잎, 뿌리, 열매 등의 모든 부분을 사용할 수 있으나, 바람직하게는 소엽맥문동의 괴경(傀莖)(일명,'덩이줄기'라 한다)이 적합하다. 한편, 본 발명의 소엽맥문동은 본 발명의 효과를 나타낼 수 있는 다양한 맥문동을 포함할 수 있다.The lobular vegetation used in the present invention (Ophiopogon japonicus, 小葉 다) is a perennial herbaceous plant belonging to the genus Liliaceae, which is called the "leaflet" because it has a particularly small and thin leaf compared to the common Liriope platyphylla . do. It grows mainly in the shade of mountains. Root stems grow to the side, and the roots are thickened like peanuts. The leaves are clustered from the bottom, linear, and butterflies 2-4 mm. Flowers blossom in May, light purple or white, with about 10 shots. The edges are membranous (膜質: translucent like thin paper), and one or two flies between the basofoams. A stalk is 7-12cm long, flat and with sharp ridges. Small flower stalks have a node in the middle or below the flower. Petals and stamens are 6 pieces each. Anther is basso but fruit is round and dark sky blue. The tuber root is used as medicinal oil as Macmundong. It is distributed in Korea, Japan, China and Taiwan. Neon Bone Carbide is known to have the effect of lowering the heat of the heart, enhancing the sound, and strengthening the lungs, refreshing, improving winter stamina, and preventing coughs and asthma. Older people with seawater asthma or those who have had lung surgery have a prescription to win the winter, and also have a fever-lowering effect, which is effective for neuralgia and rheumatism. Excellent effect can be seen. It has been reported to quench thirst, dry skin, winter cold, and fatigue. Steroid-based saponins and opiopogonin are known as the main ingredients. The leaflet vegetation used in the present invention can be used for all parts, such as petals, leaves, roots, fruit, etc., preferably tubers (傀 莖) of the leaflet vegetation (called 'tuber stem') is suitable. On the other hand, the leaflet pulsatile sinus of the present invention may include a variety of pulmonary sinus that may exhibit the effect of the present invention.
본 발명에서 제공하는 화장료 조성물은 소엽맥문동 추출물을 함유하는 것을 특징으로 한다. 본 발명에 의한 소엽맥문동 추출물은 다음과 같이 제조할 수 있다.The cosmetic composition provided by the present invention is characterized in that it contains the lobular vegetation extract. The leaflet vegetation extract according to the present invention can be prepared as follows.
본 발명의 소엽맥문동 추출물은 공지된 다양한 방법으로 추출할 수 있으나, 바람직하게는 하기와 같은 방법으로 수득될 수 있다. 먼저, 소엽맥문동의 덩이줄기에 물을 일정량 첨가한 후 환류장치 하에서 약 30 분 내지 12 시간 동안 끓이면서 추출한 후 여과하여 그 여액을 취하고 물을 첨가하여 총 량을 조정한 다음, 저온에서 1일 내지 12일 간 방치하여 생성된 침전물들을 막 여과를 실시함으로써 추출물을 수득할 수 있다.The leaflet vegetation extract of the present invention can be extracted by a variety of known methods, preferably can be obtained by the following method. First, after adding a certain amount of water to the tuber of leaflet vegetation and extracting while boiling under reflux apparatus for about 30 minutes to 12 hours, filtered and the filtrate is taken and the total amount is adjusted by adding water, then 1 to 12 days at low temperature The precipitate can be obtained by performing membrane filtration of the precipitates produced by standing for one day.
또한, 본 발명의 추출물은 추출 용매에 의한 추출물뿐만 아니라, 통상적인 정제 과정을 거친 추출물도 포함한다. 예컨대, 일정한 분자량 컷-오프 값을 갖는 한외여과막을 이용한 분리, 다양한 크로마토그래피 (크기, 전하, 소수성 또는 친화성에 따른 분리를 위해 제작된 것)에 의한 분리 등, 추가적으로 실시된 다양한 정제 방법을 통해 얻어진 분획도 본 발명의 추출물에 포함되는 것이고, 나아가, 본 발명의 추출물은 감압 증류 및 동결 건조 또는 분무 건조 등과 같은 추가적인 과정에 의해 분말 상태로 제조될 수 있다.In addition, the extract of the present invention includes not only an extract by an extraction solvent, but also an extract that has undergone a conventional purification process. Obtained by various additional purification methods, such as, for example, separation using ultrafiltration membranes having a constant molecular weight cut-off value, separation by various chromatography (manufactured for separation according to size, charge, hydrophobicity or affinity). The fraction is also included in the extract of the present invention, furthermore, the extract of the present invention may be prepared in powder form by additional processes such as distillation under reduced pressure and freeze drying or spray drying.
본 발명의 화장료 조성물은 상기 소엽맥문동 추출물을 전체 화장료 조성물에 대하여 0.001 내지 20.0 중량%를 포함하는 것이 바람직하다. 본 발명의 화장료 조성물이 0.001 중량 미만으로 상기 추출물을 포함할 경우에는 화장료 조성물의 효과가 미미하며 20.0 중량%를 초과하여 투입할 경우에는 초과투입에 따른 상승 효과가 적어 경제적이지 못하다. 더욱 바람직하기로는 본 발명의 화장료 조성물이 상기 추출물들을 0.01 내지 10.0 중량%, 더더욱 바람직하게는 0.1-5.0 중량%를 포함하는 것이 적합하다. The cosmetic composition of the present invention preferably comprises 0.001 to 20.0% by weight of the leaflet vegetation extract relative to the total cosmetic composition. When the cosmetic composition of the present invention contains the extract at less than 0.001 weight, the effect of the cosmetic composition is insignificant, and when added in excess of 20.0% by weight, the synergistic effect due to the excess input is not economical. More preferably, the cosmetic composition of the present invention comprises 0.01 to 10.0% by weight of the extract, even more preferably 0.1 to 5.0% by weight.
본 발명의 화장료 조성물에 포함되는 성분은 유효 성분으로서의 소엽맥문동 추출물 이외에 화장료 조성물에 통상적으로 이용되는 성분들을 포함하며, 예컨데 항산화제, 안정화제, 용해화제, 안료 및 향료와 같은 통상적인 보조제, 그리고 담체를 포함할 수 있다.The components included in the cosmetic composition of the present invention include components conventionally used in cosmetic compositions in addition to the leaf leaf vegetal extract as an active ingredient, and include, for example, conventional auxiliaries such as antioxidants, stabilizers, solubilizers, pigments and flavors, and carriers. It may include.
본 발명의 피부 보습용 화장료 조성물은 소엽맥문동추출물 외에 본 발명이 목적으로 하는 보습 효과를 손상시키지 않는 범위 내에서, 바람직하게는 상기 보습 효과에 상승 효과를 줄 수 있는 다른 보습 성분 등을 함유하는 것도 무방하다. 또한, 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 젤, 크림, 로션, 파우더, 비누, 계면활성제-함유 클렌징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이 등으로 제형화 될 수 있으나, 이에 한정된 것은 아니다. 보다 상세하게는, 유연 화장수, 영양 화장수, 영양 크림, 마사지 크림, 에센스, 아이 크림, 클렌징 크림, 클렌징 포옴, 클렌징 워터, 팩, 스프레이 또는 파우더의 제형으로 제조 될 수 있다.The cosmetic composition for skin moisturizing of the present invention, in addition to the leaflet vegetative extract, also contains other moisturizing ingredients and the like within the range of not impairing the moisturizing effect of the present invention. It's okay. In addition, it may be prepared in any formulation conventionally prepared in the art, for example, solutions, suspensions, emulsions, pastes, gels, creams, lotions, powders, soaps, surfactant-containing cleansing, oils, powders It may be formulated as a foundation, emulsion foundation, wax foundation and spray, but is not limited thereto. More specifically, it may be prepared in the form of a flexible lotion, nutrition lotion, nutrition cream, massage cream, essence, eye cream, cleansing cream, cleansing foam, cleansing water, pack, spray or powder.
본 발명의 제형이 페이스트, 크림 또는 젤인 경우에는 담체 성분으로 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로스 유도체, 폴리에틸렌 글라이콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용 될 수 있다.When the formulation of the present invention is a paste, cream or gel, the carrier components include animal oils, vegetable oils, waxes, paraffins, starches, trachants, cellulose derivatives, polyethylene glycols, silicones, bentonites, silica, talc or zinc oxide. Can be used.
본 발명의 제형이 파우더 또는 스프레이 인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알뤼늄 하이드록시드, 칼슘 실리케이트 또는 폴리아마이드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로하이드로카본, 프로판/부탄 또는 다이메틸 에테르와 같은 추진체를 포함 할 수 있다.When the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminium hydroxide, calcium silicate or polyamide powder may be used, especially in the case of spray, additionally chlorofluorohydrocarbon, Propellant such as propane / butane or dimethyl ether.
본 발명의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해화제 또는 유탁화제가 이용되고, 예컨데 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글라이콜, 1,3-부틸글라이콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글라이콜 또는 소르비탄의 지방족 에스테르가 있다.When the formulation of the present invention is a solution or emulsion, a solvent, solubilizer or emulsifier is used as the carrier component, for example water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol , Aliphatic esters of 1,3-butylglycol oil, glycerol aliphatic esters, polyethylene glycols or sorbitan.
본 발명의 제형이 계면-활성제 함유 클렌징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오테이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아마이드 에테르설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올 아미드, 식물성유 라놀린 유도체, 에톡실화 글리세롤 또는 지방산 에스테르 등이 이용될 수 있다.When the formulation of the present invention is a surfactant-containing cleansing, the carrier component is an aliphatic alcohol sulfate, an aliphatic alcohol ether sulfate, a sulfosuccinic acid monoester, isethiotate, imidazolinium derivatives, methyltaurate, sarcosinate, fatty acid amide. Ethersulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanol amides, vegetable oil lanolin derivatives, ethoxylated glycerol or fatty acid esters and the like can be used.
이하, 실시예와 실험예를 통하여 본 발명을 더욱 상세히 설명 하고자 한다. 하기, 실시예와 실험예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로서, 본 발명의 요지에 따라 본 발명의 범위가 이들에 의해 제한되지 않는다는 것은 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 있어서 자명할 것이다.배합량은 중량%로 나타낸다.Hereinafter, the present invention will be described in more detail with reference to Examples and Experimental Examples. The following Examples and Experimental Examples are only for more specifically describing the present invention, and the scope of the present invention is not limited by them according to the gist of the present invention. It will be apparent to the child. The blending amount is expressed in weight%.
제조예 1: 소엽맥문동 추출물의 제조Preparation Example 1 Preparation of Leaflet Vein Extract
소엽맥문동의 덩이줄기10 g을 취하여 물 100 ㎖씩을 첨가한 후 환류장치 하에서 3시간 동안 끓이면서 추출한 후 여과지로 여과하여 그 여액을 취하고 물을 첨 가하여 총 100 ㎖가 되게 조정한 다음, 조정액을 4 ℃에서 6일간 방치하여 생성된 침전물들을 0.45 um막 여과를 실시하여 소엽맥문동 추출물을 수득하였다.Take 10 g of the tuber stem of the leaflet vein and add 100 ml of water each time, extract it by boiling under reflux for 3 hours, filter it with filter paper, filter the filtrate, adjust the water to 100 ml by adding water, and then adjust the adjusting solution to 4 ℃. Precipitates produced by standing for 6 days at 0.45 um membrane filtration to obtain the lobular vegetation extract.
실험예 1: 맥문동 추출물의 세포독성 시험Experimental Example 1: Cytotoxicity Test of Macmundong Extract
화장품에 사용되는 원료로서 1차 안전성을 검증하고자, 본 발명의 소엽맥문동 추출물에 대하여 V79-4세포(차이니스 햄스터, 폐 조직 섬유 아세포의 연속 세포주)를 배양하여 MTT 시험(참고문헌: Mossman T. (1983). Rapid colorimetric assay for cellular growth & survival: application to proliferation & cytotoxicity assays. Journal of Immunological Methods, 65, 55-63)을 수행하여 세포독성을 시험하였으며, 그 결과를 표 1에 나타내었다.In order to verify the primary safety as a raw material used in cosmetics, the MTT test (Ref .: Mossman T. C.) was cultured by culturing V79-4 cells (Chinese hamster, continuous cell line of lung tissue fibroblasts) with the leaflet vegetation extract of the present invention. (1983) Rapid colorimetric assay for cellular growth & survival: application to proliferation & cytotoxicity assays.Journal of Immunological Methods, 65, 55-63) was performed to test the cytotoxicity, the results are shown in Table 1.
aIC50: Inhibitory Concentration 50, 50%의 세포를 사멸시키는 농도 a IC 50 : Inhibitory Concentration 50, 50% cell killing concentration
표 1에서 보는 바와 같이, 본 발명에 따른 맥문동 추출물의 IC50 값은 2.5로 소디움라우릴설페이트에 비하여 500배 이상 세포독성이 낮아 안전성이 우수함을 알 수 있다.As shown in Table 1, the IC 50 value of the extract of McMoon Dong according to the present invention is 2.5, which is low in cytotoxicity compared to sodium lauryl sulfate, which is excellent in safety.
실험예 2. 소엽맥문동 추출물의 클라우딘-1과 ZO-1 단백질 발현 조사Experimental Example 2 Investigation of the Expression of Cladin-1 and ZO-1 Proteins in the Extracts of Lobules and Cauliflowers
상기 소엽맥문동 추출물에 대하여 하기와 같이 클라우딘-1(Claudins-1)과 ZO-1 단백질 발현 량을 웨스턴 블롯(Western blot)으로 측정하였다. 인간 각질형성세포(Keratinocyte)를 60 mm 배양접시에 1 x 106의 밀도로 10% 소혈청(Gibco/BRL)을 포함하는 DMEM 배지(Gibco/BRL)로 37℃, 5% CO2 배양기에서 하루 동안 키웠다. 그 후 혈청이 없는 배지로 교환해 주고 시료를 0.5, 1.0% 농도로 첨가하여 24시간 동안 37℃에서 배양하였다. 그 후, 세포 배양액을 농축필터 밀리포어(Millipore)를 사용하여 단백질을 농축 후 BCA 방법 (시그마(Sigma))에 따라 단백질 정량 하여 웨스턴 블로팅(western blotting)에 사용하였다. 7% 세퍼레이팅 젤(separating gel)과 5% 스테킹 젤(staking gel)로 구성된 SDS-PAGE 젤(gel)에 같은 양의 단백질을 전기영동하고 쎄미 -드라이 트랜스퍼(semi-dry transfer) 장치(Biorad)를 사용하여 전기영동 한 단백질을 PVDF 멤브레인(membrane)으로 옮긴 후 일차항체 안티-클라우딘-1(Anti-Claudins-1)과 안티-ZO-1(Anti-ZO-1) 항체를 처리하고 반응이 끝난 다음 HRP가 컨쥬게이트된 이차 항체를 처리하고 ECL (enhanced chemiluminescence, Intron) 반응 후 엑스-레이(X-ray) 필름에 감광시켜 확인하였다. 클라우딘-1(Claudins-1)과 ZO-1단백질 발현 량은 필름에 감광된 밴드를 이미지 분석기(Image analyzer, Biorad)로 정량 하여 그 실험 결과를 표 2에 나타내었으며, 대조군으로는 1.2mM CaCl2를 이용하였다. About the lobular vegetation extract, Claudins-1 (Claudins-1) and ZO-1 protein expression levels were measured by Western blot. Human keratinocytes were cultured in DMEM medium (Gibco / BRL) containing 10% bovine serum (Gibco / BRL) at a density of 1 × 10 6 in a 60 mm culture dish in a 37 ° C., 5% CO 2 incubator for one day. Raised Thereafter, the cells were exchanged with a serum-free medium, and the samples were added at a concentration of 0.5 and 1.0% and incubated at 37 ° C. for 24 hours. Thereafter, the cell cultures were concentrated by using a concentrated filter Millipore (Millipore), and the protein was quantified according to the BCA method (Sigma) and used for western blotting. The same amount of protein was electrophoresed on a SDS-PAGE gel consisting of a 7% separating gel and a 5% staking gel and a semi-dry transfer device (Biorad). ) To transfer the electrophoretic protein to PVDF membrane, and then treated with the primary antibody Anti-Claudins-1 and anti-ZO-1 antibodies. After completion, the HRP conjugated secondary antibody was treated and confirmed by photosensitive X-ray (X-ray) film after an ECL (enhanced chemiluminescence, Intron) reaction. Claudins-1 and ZO-1 protein expression levels were determined by using an image analyzer (Biorad) on the bands exposed to the film, and the experimental results are shown in Table 2, and 1.2mM CaCl 2 was used as a control. Was used.
상기 실험예 2의 결과에서 보듯이, 맥문동 추출물 1.0%에서 클라우딘-1(Claudins-1)은 25%, ZO-1은 24% 증가하는 것으로 나타났다.As shown in the results of Experimental Example 2, cladins-1 (Claudins-1) was increased 25%, ZO-1 was increased by 24% in 1.0% of the extract.
실험예 3. 소엽맥문동 추출물의 필라그린(Filaggrin) 생성 촉진 효과Experimental Example 3. Filagrin (Flaggrin) Formation Promoting Effect
피부에서 보습에 중요한 영향을 미치는 천연보습인자의 생산을 알아보기 위하여 천연보습인자의 전구체인 필라그린(Filaggrin)의 합성을 인간 각질형성세포(Keratinocyte)에서 시험하였다. 실험예 2와 동일한 방법으로 인간 각질형성세포(Keratinocyte)를 배양 후, 소엽맥문동 추출물을 2일간 처리하였다. 처리가 끝난 후, 배지를 제거한 다음 세포만을 취하여 초음파파쇄기 (sonicator)를 이용하여 세포를 파쇄 후, 단백질만을 얻어내었다. 이 단백질을 이용하여 웨스턴 블로팅으로 합성된 필라그린의 양을 살펴보았다. 필라그린의 항체를 붙여서 발현되는 필라그린의 양을 이미지분석기(Image analyzer, Biorad)를 이용하여 수치화한 결과를 표 3에 나타내었다.To investigate the production of natural moisturizing factors that have a significant effect on moisturization in skin, the synthesis of filaggrin, a precursor of natural moisturizing factors, was tested in human keratinocytes. After culturing human keratinocytes (Keratinocyte) in the same manner as in Experimental Example 2, lobular vegetation extract was treated for 2 days. After the treatment was completed, the medium was removed and only the cells were taken. After crushing the cells by using a sonicator, only proteins were obtained. Using this protein, the amount of filaggrin synthesized by western blotting was examined. Table 3 shows the results of quantifying the amount of filaggrin expressed by the antibody of filaggrin by using an image analyzer (Image analyzer, Biorad).
이상 증가함을 알 수 있었다. 따라서 천연보습인자의 전구체인 필라그린의 합성증가를 보이므로 간접적으로 천연보습인자의 증가를 확인할 수 있었다. It was found that the increase. Therefore, the increase in the synthesis of the natural moisturizing factor pilagrin precursor was able to confirm the increase of the natural moisturizing factor indirectly.
ingredient
제조예 2: 실시예 및 비교예 1, 2Preparation Example 2 Examples and Comparative Examples 1 and 2
실시예 및 비교예 1, 2의 제조 방법은 다음과 같다. 1) 1-6을 교반하면서 70℃로 가온하여 유상 용액을 만든다. 2) 정제수에 7-8, 10-11을 넣어 교반하면서 70℃로 가온하여 수상 용액을 만든다. 3) 상기 2)에 유상 용액인 1)과 원료 9)를 혼합한 후 유화시켜 냉각한다. 4) 상기 3)에 원료 13-15 첨가하여 혼합하고 30℃까지 냉각시켜 실시예 및 비교예 1,2를 얻는다.The manufacturing methods of Examples and Comparative Examples 1 and 2 are as follows. 1) Warm 1-6 to 70 ° C while stirring to form an oily solution. 2) Add 7-8 and 10-11 to purified water and warm to 70 ℃ while stirring to make aqueous phase solution. 3) The oily solution 1) and the raw material 9) are mixed with 2), and then emulsified and cooled. 4) The raw materials 13-15 are added to 3), mixed and cooled to 30 ° C. to obtain Examples and Comparative Examples 1,2.
실험예 4: 보습 효과Experimental Example 4: Moisturizing Effect
상기 실시예 및 비교예 1, 2에서 제조된 각 화장료의 보습력을 평가하기 위하여, 각 화장료가 도포된 피부를 대상으로 하여 수분 보유능 및 수분 증발량을 다음과 같이 측정하였다.In order to evaluate the moisturizing power of each of the cosmetic preparations prepared in Examples and Comparative Examples 1 and 2, the moisture retention capacity and the water evaporation amount were measured as follows on the skin to which each cosmetic was applied.
실험예 4-1: 수분 보유 능의 측정Experimental Example 4-1: Measurement of Moisture Retention Capacity
상기 표 4의 조성으로 제조된 화장료에 대하여 피부 보습력 개선효과를 실험하였다. 피부 질환이 없는 20∼30대 60명을 대상으로 1조 당 20명씩 3개조로 나누어, 각 조에 각각 실시예, 비교예 1, 2를 주고, 매일 2회씩 1개월간 얼굴 및 전박부에 도포하게 하였다. 미리 도포 시작 전 온, 항습 조건(24℃, 습도 40%)에서 피부수분측정기(corneometer: CM820 courage Khazaka electronic GmbH, Germany)를 이용하여 피부 전기 전도도를 측정하여 기본 값을 삼고, 1주, 2주, 4주 경과 후 및 도포 중지 후 2주 경과(6주 경과) 후의 피부 전기 전도도를 측정하였다. 그 결과는 하기 표 5에 나타내었다.Experimental effect of improving the skin moisturizing power for the cosmetic prepared in the composition of Table 4. 60 people in their 20s to 30s without skin diseases were divided into three groups of 20 people per group, and each group was given an Example, Comparative Examples 1 and 2, and applied to the face and forearm twice a day for 1 month. . Before starting the application, measure skin electrical conductivity using corneometer (CM820 courage Khazaka electronic GmbH, Germany) at temperature and humidity conditions (24 ℃, 40% humidity). Skin electrical conductivity was measured after 4 weeks and after 2 weeks (6 weeks). The results are shown in Table 5 below.
실험예 4-2: 수분 증발량의 측정Experimental Example 4-2: Measurement of Water Evaporation Amount
팔의 상박 부위에 테이프 스트리핑 (tape stripping)을 실시하여 피부의 방어막을 약화시킨 후, 22℃ 및 상대습도 45%의 항온 항습실에서 상기 실시예 및 비교예 1, 2에서 제조된 각 화장료를 30명의 피시험자 하박 안쪽에 일정량 (0.03 g/16 ㎠)을 도포한 후, 수분증발량기(Tewameter TM300, Courage + Khazaka사, 독일연방국)를 이용하여 12 시간마다 1분 간격으로 5회씩 수분 증발량을 측정하여 평균값을 구하였으며, 아무런 처리를 하지 않은 정상 피부를 대조군으로 사용하였다. 그 결과는 하기 표 6에 나타내었다.After tape stripping on the upper arm of the arm to weaken the skin's protective film, 30 cosmetics prepared in Examples and Comparative Examples 1 and 2 were prepared in a constant temperature and humidity chamber of 22 ° C. and 45% relative humidity. After applying a certain amount (0.03 g / 16 ㎠) to the inside of the Habakkuk test subject, using a water evaporator (Tewameter TM300, Courage + Khazaka Co., Germany), measure the amount of water evaporation 5 times at 1 minute intervals every 12 hours The mean value was obtained and normal skin without any treatment was used as a control. The results are shown in Table 6 below.
상기 실험예 4-1 및 4-2의 결과에서 보듯이, 본 발명의 실시예 화장료가 비교예 1, 2의 화장료에 비해서 피부의 전기 전도도가 높고, 적은 수분 손실 량을 나타내었다. 피부 전기 전도도는 피부 수분량에 비례하므로, 실시예의 피부 수분 함량 증가 효과가 매우 우수함을 확인할 수 있다. 또한 실시예의 경우 사용 중지 2주 후(총 6주 후)에도 비교예 1, 2에 비하여 수분 함량이 높게 유지되는 것으로 보아 장기적인 보습 효과가 있음을 알 수 있다. 따라서, 소엽맥문동 추출물을 함유하는 화장료가 매우 우수한 보습 효과를 나타냄을 알 수 있다.As shown in the results of Experimental Examples 4-1 and 4-2, the cosmetic agent of the present invention exhibited higher electrical conductivity of the skin and less water loss than the cosmetic agents of Comparative Examples 1 and 2. Since the skin electrical conductivity is proportional to the skin moisture content, it can be seen that the skin moisture content increase effect of the embodiment is very excellent. In addition, in the case of the Example 2 weeks after the suspension of use (after 6 weeks in total) it can be seen that the moisture content is maintained as compared to Comparative Examples 1 and 2 have a long-term moisturizing effect. Therefore, it can be seen that the cosmetic containing the leaflet vegetation extract shows a very excellent moisturizing effect.
실험예 5: 제형의 안정성 시험Experimental Example 5: Stability Test of the Formulation
상기 본 발명의 맥문동 추출물을 함유한 화장료에 대한 안정성 시험을 하기의 방법으로 실시하였다.The stability test for the cosmetic containing the extract of the present invention was carried out by the following method.
화장료의 안정성을 시험하기 위해 상기 실시예 및 비교예 1, 2를 45℃로 일정하게 유지되는 항온조에서 불투명 초자 용기에 담아 12주 동안 보관하고 또한 4℃로 일정하게 유지되는 완전히 차광된 냉장고 내에서 불투명 초자 용기에 담아 12주 동안 보관한 후, 변색 및 변취, 분리 정도를 비교 측정하였다. 그 결과는 하기 표 7에 정리되어 있다. 이 때 제품 변색 및 변취, 분리 정도를 다음의 6등급으로 분류하여 평가하였다: 0: 변화 없음; 1: 극히 조금 분리(변색); 2: 조금 분리(변색); 3: 조금 심하게 분리(변색); 4: 심하게 분리(변색); 및 5: 극히 심하게 분리(변색).In order to test the stability of the cosmetics, Examples and Comparative Examples 1 and 2 were kept in an opaque glass container in a constant temperature bath at a constant temperature of 45 ° C. and stored for 12 weeks in a completely shaded refrigerator kept at a constant temperature of 4 ° C. After storing in an opaque glass container for 12 weeks, the discoloration, odor, and degree of separation were measured. The results are summarized in Table 7 below. At this time, the degree of product discoloration, odor and separation were evaluated by classifying into the following six grades: 0: no change; 1: very little separation (discoloration); 2: a little separation (discoloration); 3: slightly severe separation (discoloration); 4: severe separation (discoloration); And 5: extremely severe separation (discoloration).
표 7에서 알 수 있는 바와 같이, 실시예와 비교예 1, 2는 45℃에서 변색이나 변취, 분리 현상이 거의 없이 안정하였고 이는 맥문동 추출물이 제형 내에서 안정한 상태로 존재함을 나타낸다.As can be seen in Table 7, Examples and Comparative Examples 1 and 2 were stable at 45 ° C. with little discoloration, discoloration, or separation, indicating that the Macmundong extract was present in a stable state in the formulation.
이하 상기한 실험예의 결과를 근거로 하여 본 발명의 소엽맥문동 추출물을 함유하는 화장료를 조성하여 제시한다. 그러나, 본 발명의 조성물을 하기의 제형예들로 한정하고자 하는 것은 아니다.Hereinafter, based on the results of the above experimental example, to present a cosmetic composition containing the leaflet vegetation extract of the present invention. However, the composition of the present invention is not intended to be limited to the following formulation examples.
제형예 1: 유연화장수(스킨로션)Formulation Example 1: Softener (Skin Lotion)
하기 표에 나타난 바와 같이 유연화장수를 통상의 방법에 따라 제조하였다.As shown in the following table, the softening lotion was prepared according to a conventional method.
제형예 2. 영양화장수(밀크로션)Formulation Example 2. Nutrients (Milk Lotion)
하기 표에 나타난 바와 같이 영양화장수를 통상의 방법에 따라 제조하였다.Nutrients were prepared according to a conventional method as shown in the table below.
제형예 3. 영양크림Formulation Example 3. Nutrition Cream
하기 표에 나타난 바와 같이 영양크림을 통상의 방법에 따라 제조하였다.Nutritious cream was prepared according to a conventional method as shown in the following table.
제형예 4. 마사지크림Formulation Example 4 Massage Cream
하기 표에 나타난 바와 같이 마사지크림을 통상의 방법에 따라 제조하였다.Massage cream was prepared according to a conventional method as shown in the table below.
제형예 5. 팩Formulation Example 5 Pack
하기 표에 나타난 바와 같이 팩을 통상의 방법에 따라 제조하였다.Packs were prepared according to conventional methods as shown in the table below.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090012314A KR20100093223A (en) | 2009-02-16 | 2009-02-16 | Cosmetic composition containing an extract of ophiopogon japonicus for skin miosture |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090012314A KR20100093223A (en) | 2009-02-16 | 2009-02-16 | Cosmetic composition containing an extract of ophiopogon japonicus for skin miosture |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20100093223A true KR20100093223A (en) | 2010-08-25 |
Family
ID=42757688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090012314A Ceased KR20100093223A (en) | 2009-02-16 | 2009-02-16 | Cosmetic composition containing an extract of ophiopogon japonicus for skin miosture |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20100093223A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8857741B2 (en) | 2012-04-27 | 2014-10-14 | Conopco, Inc. | Topical spray composition and system for delivering the same |
KR20180003920A (en) * | 2016-07-01 | 2018-01-10 | 주식회사 엘지생활건강 | Composition for skin improvement containing liriopesides B |
WO2020101221A1 (en) * | 2018-11-15 | 2020-05-22 | 김영배 | Composition containing rubus coreanus oil as active ingredient for improvement of skin barrier functions |
-
2009
- 2009-02-16 KR KR1020090012314A patent/KR20100093223A/en not_active Ceased
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8857741B2 (en) | 2012-04-27 | 2014-10-14 | Conopco, Inc. | Topical spray composition and system for delivering the same |
US9751097B2 (en) | 2012-04-27 | 2017-09-05 | Conopco, Inc. | Topical spray composition to benefit skin |
KR20180003920A (en) * | 2016-07-01 | 2018-01-10 | 주식회사 엘지생활건강 | Composition for skin improvement containing liriopesides B |
WO2020101221A1 (en) * | 2018-11-15 | 2020-05-22 | 김영배 | Composition containing rubus coreanus oil as active ingredient for improvement of skin barrier functions |
KR20200056819A (en) * | 2018-11-15 | 2020-05-25 | 김영배 | Composition for improving skin barrier function comprising rubus coreanus miquel oil |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20200026646A (en) | Cosmetic Composition for Improving Skin Condition Comprising Plant cell complex cultures to improve skin radiance and vitality | |
KR102473093B1 (en) | Cosmetic composition for improving skin condition comprising hemp seed oil, plant callus culture filtrate and peptides as active ingredient | |
KR101663946B1 (en) | Cosmetic composition containing an ginsenoside Rg3 reinforced extract of fermentative Ginseng flower(Panax ginseng C. A. Meyer) by Aureobasidium pullulans | |
KR102187896B1 (en) | Cosmetic composition for improvement of cell moisturizing, intercellular moisturizing, and barrier moisturizing with plant extract | |
KR101312965B1 (en) | The cosmetic composition for anti-wrinkle comprising the mixture of extract of Allium cepa, Symphytum officinale, Eclipta prostrate, and Theobroma cacao | |
KR101055963B1 (en) | Cosmetic composition for promoting exfoliation | |
KR100443588B1 (en) | Cosmetic composition containing paeonia suffruticosa andrews extract and albizzia julibrissin dura extract having anti-ageing effect | |
KR101124971B1 (en) | Cosmetic composition containing Salicornia herbacea callus Extracts and Laminaria digitata Extracts for Improving Skin Wrinkle or enhancing skin Elasticity | |
KR100903654B1 (en) | Cosmetic composition containing Hachocho extract and adenosine | |
KR20180001652A (en) | Cosmetic composition for skin barrier comprising extract of Buddleia officinalis or fractions thereof | |
KR101896563B1 (en) | Cosmetic composition containing Ligustrum lucidum Aiton extract for moisturizing the skin | |
KR20100093223A (en) | Cosmetic composition containing an extract of ophiopogon japonicus for skin miosture | |
KR100955572B1 (en) | Cosmetic composition containing noni supercritical extract | |
KR20080093500A (en) | Roe deer urine extract | |
KR101587447B1 (en) | Cosmetic composition with BL-S extract by the supercritical extraction with the effect of skin sebum control, skin barrier intention, skin moisture control and skin protection | |
KR101074132B1 (en) | Cosmetic composition containing Salicornia herbacea callus extracts and Pelvetia Canaliculata extracts for improving skin wrinkle or enhancing elasticity | |
KR20110089793A (en) | Cosmetic composition | |
KR101214344B1 (en) | Cosmetics composition containing fermented rice bran and licorice extract | |
KR101363029B1 (en) | The cosmetic composition for anti-oxident and anti-aging of the skin comprising the Gelidium amansii, Undaria pinnatifida, wheat bud and Monarda horsemint | |
KR20110034742A (en) | Cosmetic composition for skin improvement containing ginsenoside egg | |
KR100849019B1 (en) | Cosmetic composition containing white lupine extract | |
KR20090078084A (en) | Cosmetic composition for improving skin wrinkles containing tofu extract and adenosine | |
KR102700527B1 (en) | Cosmetic composition containing morus alba fruit, artemisia princeps leaf and prunella vulgaris and having skin moisturizing effect and skin surface improvement effect | |
KR101533018B1 (en) | Cosmetic composition containing extracts of ramulus mori as active ingredient | |
EP3381441B1 (en) | External use skin composition for antiaging containing germinated glycine gracilis extract as active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20090216 |
|
PA0201 | Request for examination | ||
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20110216 Patent event code: PE09021S01D |
|
E601 | Decision to refuse application | ||
PE0601 | Decision on rejection of patent |
Patent event date: 20110425 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20110216 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |